Insights into Ready-to-Use Packaging Solutions for Injectables
On Wednesday Nov. 6, 2019, Gregor Deutschle and Dr. Nicolas Eon, both from Schott, will share insights into ready-to-use solutions for complex biotech drugs.
On Wednesday Nov. 6, 2019, Gregor Deutschle (director business development sterile solutions, Schott Pharmaceutical Systems) and Dr. Nicolas Eon (senior global product manager, Schott) will share insights into ready-to-use solutions for complex biotech drugs.
With the advent of highly complex biologics, personalized medicines, along with cell and gene therapies, there is a growing requirement for greater efficiency, flexibility, and simplicity in the manufacturing process of injectables. In the presentation, Deutschle and Eon will use the example of Schott’s iQ ready-to-use platform to provide insights into how universal containers can benefit manufacturers compared with bulk ones and provide quicker and simpler drug development, manufacture, and delivery.
Ready-to-Use Packaging Solutions to Transform Injectable Drug ManufacturingWednesday Nov. 6, 2019 16:30–17:00 InnoPack & P-MEC Theatre (110D50)
Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines
April 30th 2024In this episode fo the Drug Solutions Podcast, etherna’s vice-president of Technology and Innovation, Stefaan De Koker, discusses the merits and challenges of using mRNA as the foundation for therapeutics in oncology as well as for vaccines.
Pharmaceutical Tariffs Are Imminent: How Industry is Bracing for Impact
April 16th 2025On April 14, 2025, the Trump Administration launched a national security-driven investigation into pharmaceuticals, a move that will likely result in tariffs being placed on pharmaceutical drugs, ingredients, and other components that are imported from outside of the United States.
